Bone marrow failure research program vision setting, pre-application screening, programmatic review and general program support services

Ended Awarded Last action

Contract number
HT942525F0141
Awardee
Awarding agency
Obligated
$150,839

Award facts

Opportunity
Contract value 100% obligated
$150,839.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 $56,773
Terminate for Convenience P00001 · Bone marrow failure research program $0
Original award $94,066

About this award

The Defense Health Agency issued a $150,839.42 delivery order to Leidos, Inc. on May 1, 2025, for bone marrow failure research program vision setting, pre-application screening, programmatic review, and general program support services, with final completion due April 30, 2026.

Place of performance is Frederick, Maryland. The order is priced on a cost-plus-fixed-fee basis with no set-aside applied.

Quick answers

Who was awarded contract HT942525F0141?

HT942525F0141 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on May 1, 2025.

How much is contract HT942525F0141 worth?

The government has obligated $150,839 on HT942525F0141.

Is contract HT942525F0141 an order under another contract?

Yes. HT942525F0141 is a delivery order under HT942523D0002, an indefinite delivery contract.

Was contract HT942525F0141 competed?

The extent of competition for HT942525F0141 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award